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ABSTRACT  
Facioscapulohumeral Muscular Dystrophy (FSHD) is an autosomal dominant myopathy 
with a strong epigenetic component. It is associated with deletion of a macrosatellite repeat leading 
to over-expression of the nearby genes. Among them, we focused on FSHD Region Gene 1 (FRG1) 
since its over-expression in mice, X. laevis and C. elegans leads to muscular dystrophy-like defects, 
suggesting that FRG1 plays a relevant role in muscle biology. Here we show that, when over-
expressed, FRG1 binds and interferes with the activity of the histone methyltransferase Suv4-20h1 
both in mammals and Drosophila. Accordingly, FRG1 over-expression or Suv4-20h1 knockdown 
inhibits myogenesis. Moreover, Suv4-20h KO mice develop muscular dystrophy signs. Finally, we 
identify the FRG1/Suv4-20h1 target Eid3 as a novel myogenic inhibitor that contributes to the 
muscle differentiation defects. Our study suggests a novel role of FRG1 as epigenetic regulator of 
muscle differentiation and indicates that Suv4-20h1 has a gene-specific function in myogenesis. 
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INTRODUCTION 
 
 Facioscapulohumeral muscular dystrophy (FSHD, OMIM 158900) is the third most 
common myopathy, exhibits autosomal dominant inheritance and no effective treatment is currently 
available (Cabianca and Gabellini, 2010). FSHD typically arises with a reduction of facial and 
shoulder girdle muscle mass. The disease may extend to abdominal and pelvic girdle muscles 
impairing the ability to walk. Although FSHD is primarily a disease of skeletal muscle, up to 75% 
of FSHD patients also present vascular defects (Fitzsimons et al., 1987; Osborne et al., 2007; 
Padberg et al., 1995). 
FSHD is characterized by extreme variability. Asymmetric distribution of muscle wasting 
and gender differences in the severity of the phenotype are often observed (Tonini et al., 2004; Zatz 
et al., 1998). Moreover, the onset, the progression and the severity of the phenotype, even between 
individuals carrying the same genetic mutation, differ dramatically among patients. Notably, several 
monozygotic-twin discordances for FSHD have been reported (Griggs et al., 1995; Hsu et al., 1997; 
Tawil et al., 1993; Tupler et al., 1998). Although the molecular basis of this heterogeneity is not 
fully understood, an increasing body of evidence suggests that it derives from the interplay of 
complex genetic and epigenetic events (Neguembor and Gabellini, 2010). 
FSHD is associated with reduction in the copy number of a macrosatellite repeat, called 
D4Z4, located at the subtelomeric region of chromosome 4 long arm, in 4q35 (Wijmenga et al., 
1992). In healthy individuals, the number of repeats varies between 11 and 100, while FSHD 
patients carry 1 to 10 repeats (van Deutekom et al., 1993). The reduction in D4Z4 copy number 
causes a Polycomb/Trithorax epigenetic switch leading to the over-expression of several genes 
within the FSHD region (Cabianca et al., 2012). The unusual nature of the mutation that causes 
FSHD and its complex effect on chromatin surrounding the 4q35 region makes it highly unlikely 
that the root cause of the disease can be attributed to a single gene. Since expression of multiple 
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genes is affected, the molecular pathogenesis of FSHD has been challenging to untangle, and as yet 
no therapy is available for FSHD patients. The two most important FSHD candidate genes are the 
D4Z4 repeat gene double homeobox 4 (DUX4) (Lemmers et al., 2010; Snider et al., 2009; Snider et 
al., 2010) and the proximal gene FSHD Region Gene 1 (FRG1) (Gabellini et al., 2002). DUX4 
transgenic mice have been recently described (Krom et al., 2013). Despite they display a DUX4 
expression pattern and an alteration of DUX4 target genes similar to FSHD patients,  a lot of effort, 
DUX4 transgenic mice do not display any obvious muscle phenotype (Krom, et al., 2013)showing 
muscle pathology are currently not available. On the contrary, FRG1 transgenic mice develop 
muscular dystrophy (Gabellini et al., 2006). In addition, studies conducted in X. laevis and C. 
elegans revealed that frg1 is required for normal muscle development and its over-expression 
causes muscle defects and vascular abnormalities correlated with the clinical findings from FSHD 
patients (Hanel et al., 2009; Liu et al., 2010; Wuebbles et al., 2009). 
FRG1 is a dynamic nuclear and cytoplasmic shuttling protein that, in skeletal muscle, is also 
localized to the sarcomere (Hanel et al., 2011). Interestingly, over-expressed FRG1 is almost 
completely nuclear and is localized in nucleoli, Cajal bodies, and actively transcribed chromatin 
(Sun et al., 2011; van Koningsbruggen et al., 2004). Although, it has been associated with RNA 
biology (Gabellini, et al., 2006; Sun, et al., 2011; van Koningsbruggen, et al., 2004; van 
Koningsbruggen et al., 2007), the molecular and cellular mechanism that follows FRG1 over-
expression leading to muscular defects is currently unknown. 
Here, we show that FRG1 directly binds to Suppressor of variegation 4-20 homolog 1 
(Suv4-20h1), a histone methyltransferase previously involved in constitutive heterochromatin 
formation (Benetti et al., 2007; Gonzalo et al., 2005; Schotta et al., 2004). Our data indicate that 
Suv4-20h1 is required for myogenic differentiation and that FRG1 over-expression interferes with 
its function. Finally, we show that EP300 interacting inhibitor of differentiation 3 (Eid3) is an 
FRG1/Suv4-20h1 epigenetic target. Based on these findings, we propose that FRG1 and Suv4-20h1 
are novel epigenetic regulators of muscle differentiation. 
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RESULTS 
 
FRG1 directly interacts with the histone methyltransferase SUV4-20H1. 
The molecular mechanism that follows FRG1 over-expression is currently unknown. To 
address this, we performed an unbiased yeast two-hybrid screening to identify potential interaction 
partners. In accordance with van Koningsbruggen et al. 2007, we identified Karyopherin alpha 2 
(KPNA2) as first interactor with 30% of positive clones. The second interactor identified (18.8% of 
positive clones) Among the positive clones, we isolated a clone correspondeding to the C-terminus 
region (517-885) of human Suppressor of variegation 4-20 homolog 1 (SUV4-20H1), a histone 
methyltransferase responsible for the di- and tri-methylation of Lysine 20 of Histone 4 (H4K20me2 
and H4K20me3) (Schotta, et al., 2004). These epigenetic modifications play a crucial role in the 
control of repressive heterochromatin (Schotta, et al., 2004). Interestingly, there are several 
indications that H4K20me3 is implicated in muscle differentiation (Biron et al., 2004; Terranova et 
al., 2005; Tsang et al., 2010). The levels of H4K20me3 dramatically increase during muscle 
differentiation (Biron, et al., 2004; Terranova, et al., 2005) and it has been suggested that this could 
act as a switch in the myogenic program (Tsang, et al., 2010). Therefore, SUV4-20H1 appeared as 
an interesting FRG1 interacting partner that could provide a molecular clue in the myogenic defects 
associated with FRG1 over-expression. 
Unfortunately, antibodies functioning in co-immunoprecipitation with endogenous FRG1 
and Suv4-20h1 are not available. Moreover, Suv4-20h1 is tightly bound to chromatin and very high 
salt is required to quantitatively extract it . Accordingly, endogenous interaction between Suv4-
20h1 and other proteins has never been reported . For these reasons, We first investigated the 
FRG1/SUV4-20H1 interaction in vivo by co-immunoprecipitation and found that endogenous 
SUV4-20H1 interacts with over-expressed FRG1 (Figure 1A). To further confirm this interaction, 
we used co-immunoprecipitation with epitope-tagged proteins to confirm FRG1/SUV4-20H1 
interaction in vivo and showed that FRG1 binds to both human and murine Suv4-20h1 in vivo 
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(Supplementary Figure S1A–B). Interestingly, we found that FRG1 tends to co-immunoprecipitate 
more abundantly than human or murine Suv4-20h1. Although co-immunoprecipitation assays 
cannot define the stoichiometry of an interaction, it is possible that multimers of FRG1 could bind 
to Suv4-20h1 since it has been recently shown that FRG1 forms dimers and tetramers to establish 
protein-protein interactions . Next, we performed in-vitro pull-down assays using purified, 
recombinant full-length proteins as well as the C-terminus region of Suv4-20h1 to validate our yeast 
two-hybrid results. Accordingly, we established that FRG1 and Suv4-20h1 interact in a direct 
manner and that the binding occurs through the C-terminal region of the protein (Figure 1BC). In 
particular, from a panel of truncated forms of Suv4-20h1 (Figure 1CD), we found that the Suv4-
20h1(509-630) region was sufficient for FRG1 binding in vitro (Figure 1DE). Notably, we also 
showed by co-immunoprecipitation that the Suv4-20h1(509-630) region is sufficient to interact with 
FRG1 in vivo (Figure 1EF). 
We then sought to investigate the FRG1 and SUV4-20H1 interaction at the cellular level. 
Figure 2 shows that, when expressed singularly, the two proteins displayed distinct localizations in 
line with previous reports (Hanel, et al., 2011; Schotta, et al., 2004; van Koningsbruggen, et al., 
2004; van Koningsbruggen, et al., 2007). As previously shown, SUV4-20H1 was localized in 
DAPI-dense, heterochromatic regions (Schotta, et al., 2004), while FRG1 was broadly distributed in 
the nucleus with nucleolar enrichment (Hanel, et al., 2011; van Koningsbruggen, et al., 2004; van 
Koningsbruggen, et al., 2007). Strikingly, in cells over-expressing FRG1, SUV4-20H1 was de-
localized from heterochromatin, showed a wider nucleoplasmic distribution and co-localized with 
FRG1 (Figure 2A). Several controls support the specificity of these results. Firstly, the result was 
independent from the position or the nature of the tag fused to SUV4-20H1 (data not shown). 
Secondly, the localization of a SUV4-20H1 isoform lacking the FRG1 binding domain (SUV4-
20H1.2) (Tsang, et al., 2010), was not altered in cells over-expressing FRG1 (Figure 2B). Thirdly, 
SUV4-20H2, a heterochromatin enriched histone methyltransferase that shares the enzymatic 
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activity of SUV4-20H1 (Schotta, et al., 2004), was unaffected by FRG1 over-expression (Figure 
2C). 
Collectively, our results suggest that FRG1 over-expression specifically alters SUV4-20H1 
sub-nuclear distribution titrating it away from some target loci. 
 
The functional interaction between FRG1 and SUV4-20H1 is evolutionarily conserved in 
Drosophila.  
Since the Drosophila homolog of SUV4-20H1, dSuv4-20, was identified as a dominant 
suppressor of position effect variegation (PEV) (Schotta, et al., 2004), we asked whether dFRG1, 
the Drosophila homolog of FRG1, could also have an effect on PEV. While no dFRG1 mutant is 
available, we took advantage of available dFRG1 RNAi flies (Vienna Drosophila RNAi Stock 
center). As previously done (Schotta, et al., 2004), PEV analyses were conducted on the T(2;3)SbV 
background where the dominant negative marker Stubble (SbV), which gives rise to short bristles, is 
translocated close to pericentric heterochromatin being hence subjected to PEV-dependent silencing 
(Moore et al., 1983; Sinclair et al., 1983). When crossed into the T(2;3)Sbv background, Suv4-
20BG00814 mutation leads to de-repression of the dominant Stubble allele (Figure S12A; Fisher exact 
test: p<0.0001, n=400 from 20 flies), as previously reported (Schotta, et al., 2004). Conversely, 
UAS-FRG1RNAi (FRG1RNAi) flies showed stronger silencing of pericentric heterochromatin compared 
to the control (Figure S21A; Fisher exact test: p<0.0001, n=400 from 20 flies). To investigate the 
molecular mechanism, we monitored the levels of the dSuv4-20-associated repressive histone mark 
H4K20me3 on chromosomal spreads from salivary glands. As previously reported (Schotta, et al., 
2004), Suv4-20BG00814 mutation lead to a decrease in H4K20me3 compared to controls (Figure 
S12C-D; unpaired t test: p<0.0001, n=5). On the contrary, FRG1RNAi flies displayed increased 
H4K20me3 levels (Figure S12C-D; unpaired t test: p<0.0001, n=5). These data indicate that the 
interaction between FRG1 and SUV4-20H1 is evolutionarily conserved and suggest that the 
regulation of Suv4-20 function is part of the normal FRG1 activity in Drosophila. 
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FRG1 over-expression or Suv4-20h1 knockdown inhibits myogenic differentiation of C2C12 
muscle cells. 
The regulation of H4K20 methylation has been implicated in muscle differentiation (Biron, 
et al., 2004; Terranova, et al., 2005). Moreover, over-expression of Suv4-20h proteins can enhance 
myogenic differentiation (Tsang, et al., 2010). Based on our results, we reasoned that over-
expression of FRG1 could interfere with Suv4-20h1 function. To verify this hypothesis, we 
investigated the myogenic differentiation of C2C12 muscle cells over-expressing FRG1 or 
knockdown for Suv4-20h1. Both FRG1 over-expression and Suv4-20h1 knockdown, using three 
independent shRNAs, were able to reduce the myogenic differentiation ability of C2C12 cells 
(Figure 3A–D; paired t test: p=0.0067, n=3 and one-way Anova test: p<0.0001, n=3 respectively). 
Noteworthy, low levels of FRG1 over-expression and a partial Suv4-20h1 knockdown were 
sufficient to observe this phenotype (Figure 3E–F). These results indicate that appropriate 
expression levels of both proteins are required for muscle differentiation in C2C12 cells. 
Our data suggest that the interference with Suv4-20h1 function is an important mechanism 
through which FRG1 over-expression affects myogenic differentiation. Based on this, we reasoned 
that over-expression of SUV4-20H1 in FRG1 over-expressing cells could rescue their myogenic 
defect. Since the constitutive over-expression of SUV4-20H1 is not well tolerated by C2C12 
myoblasts (Tsang, et al., 2010), we used an inducible SUV4-20H1_ERα fusion, allowing the 
translocation of the protein to the nucleus upon 4-hydroxytamoxifen (4-OHT) treatment. By 
performing differentiation experiments, we observed a partial but significant amelioration of the 
phenotype in SUV4-20H1_ERα/FRG1 over-expressing cells treated with 4-OHT compared to 
control cell lines (FRG1) (Figure 4A-C; two way Anova test, p= 0.0406; n=3). Overall, these results 
indicate that FRG1 over-expression inhibits muscle differentiation at least in part by interfering 
with Suv4-20h1 function. 
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Muscle-specific Suv4-20h knockout mice develop muscular dystrophy signs. 
 Suv4-20h1 and the related enzyme Suv4-20h2 share functional redundancy in muscle 
(Schotta et al., 2008). To further investigate the role of Suv4-20h on muscle biology, we crossed 
Suv4-20h1-/flox_Suv4-20h2-/- mice with transgenic mice expressing the cre recombinase gene 
selectively in the skeletal muscle to obtain Suv4-20h1_Suv4-20h2 muscle-specific double knockout 
(mDKO) mice. Unfortunately, we obtained only a partial excision of the Suv4-20h1flox allele and a 
partial reduction of Suv4-20h1 expression (Supplementary Figure 5S2A-B), resulting in significant 
residual H4K20me3 levels in the skeletal muscle (Supplementary Figure 5S2C). Nevertheless, 
mDKO mice displayed several signs of muscular dystrophy, including necrosis (Figure 5DA–EB; 
Mann-Whitney test: p=0.0079, n=5) and an increased number of centrally-nucleated myofibers 
(Figure 5AD and 5FC; Mann-Whitney test: p=0.0079, n=5). Collectively, these results suggest that 
Suv4-20h1 activity plays a relevant role in muscle biology and the interference with Suv4-20h1 
function might contribute to the muscular dystrophy signs associated with FRG1 over-expression. 
 
The novel inhibitor of differentiation Eid3 is an FRG1/Suv4-20h1 target involved in the 
myogenic defects caused by FRG1 over-expression. 
Based on our results, we hypothesized that FRG1 could repress myogenesis at least in part 
by binding to Suv4-20h1 and interfering with its function. While Suv4-20h1 has been mainly 
associated with establishment and maintenance of constitutive heterochromatin, in particular at 
pericentric regions (Schotta, et al., 2004), we found no evidence of global changes in H4K20me3 in 
FRG1 over-expressing cells (data not shown)and a slight reduction in Suv4-20h1 knock-down cells 
compared to controls (Supplementary Figure S3). This result is expected since Suv4-20h2 is able to 
compensate for the lack of Suv4-20h1 in pericentric heterochromatin regions that constitute the 
major target of Suv4-20h proteins (Schotta, et al., 2008). Given this, we hypothesized that FRG1 
could act at a gene-specific level by hindering the recruitment of Suv4-20h1 to a subset of its targets 
preventing their silencing. For example, the over-expression of FRG1 could prevent the silencing of 
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“myogenic inhibitors” by Suv4-20h1. To test our hypothesis, we focused on the differential 
expression of differentiation inhibitor genes in skeletal muscles from FRG1 mice compared to WT 
controls (Xynos et al., 2013)(Xynos et al, submitted). Among the differentially expressed genes, 
DNA microarray and qRT-PCR validation (Supplementary Figure S43) identified the up-regulation 
of EP300 interacting inhibitor of differentiation 3 (Eid3) (Bavner et al., 2005). Despite its name, no 
information is available toward the biological function of Eid3. To understand if Eid3 could play a 
role in myogenic differentiation, we first analysed its expression levels in both primary and C2C12 
muscle cells and we found that Eid3 is normally silenced during myogenic differentiation (Figure 
6A-B; unpaired t test: p<0.0001, n=3 and one sample t test: p=0.0052, n=3 respectively). To assess 
whether its repression is required for muscle differentiation, we generated stable Eid3 over-
expressing C2C12 cells (pH-Eid3) where we observed that Eid3 over-expression reduces myogenic 
differentiation compared to control cells line (pFH) (Figure 6C-E; paired t test: p=0.0057, n=3), 
thus suggesting that Eid3 acts as an inhibitor of muscle differentiation. 
Interestingly, we found that Eid3 expression remains significantly higher in muscles and 
C2C12 cells over-expressing FRG1 (Figure 7A-B; paired t test: p=0.0039, n=5 and one sample t 
test: p=0.0025, n=4 respectively). Importantly, increased Eid3 expression was already present in 
young, pre-dystrophic FRG1 mice indicating that altered Eid3 expression is not simply secondary to 
muscle wasting (Figure 7A; paired t test: p=0.0039, n=5). Moreover, Eid3 over-expression was 
significantly higher in muscles that are highly affected in FRG1 mice (vastus lateralis) compared to 
mildly affected muscles (biceps brachii), suggesting that de-regulation of Eid3 expression correlates 
with the severity of the disease in different muscles (Figure 7C; paired t test: p=0.0086, n=3). Eid3 
expression was also significantly increased in muscles from mDKO mice and in C2C12 muscle cells 
knockdown for Suv4-20h1 (Figure 7D-E; unpaired t test: p=0.0019, n=5 and one sample t test: 
p=0.0039, n=4 respectively), suggesting that FRG1 over-expression affects Eid3 expression through 
Suv4-20h1. Intriguingly, we observed that EID3 expression was significantly up-regulated in 
biopsies of FSHD patients compared to healthy subjects (Figure 7F; one-way Anova test: 
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p=0.00290485, n=73–4); while EID3 levels were normal in patients affected by other types of 
Becker muscular dystrophy (Figure 7F, n=8). Similar results were obtained for FRG1 (Figure 7G, 
one-way Anova test: p=0.0013, n=7-8), while of SUV4-20H1 and β-glucuronidase (GUS), a gene 
with stable expression in FSHD (Krom et al., 2012), were not altered in FSHD patients compared to 
controls (Supplementary Figure S5), suggesting that FRG1 and EID3 up-regulation areis not a 
general feature of muscular dystrophies. Notably, EID3 up-regulation in FSHD patients was 
significantly correlated with increased FRG1 levels (Figure 7H, Pearson test: R2=0.6611,: 
p<0.0001=0.0213, n=227). 
To determine if the aberrant Eid3 up-regulation could be associated to a lack of epigenetic 
silencing by Suv4-20h1, we investigated the levels of the Suv4-20h1-associated repressive histone 
mark, H4K20me3, at the Eid3 promoter. Chromatin immunoprecipitation revealed that H4K20me3 
levels were significantly reduced at the Eid3 genomic regions spanning -6 to -2 kb from the 
transcription start site, both in FRG1 over-expressing and Suv4-20h1 knockdown C2C12 muscle 
cells (Figure 7IG-JH; two-way Anova test: p=0.0099 and p=0.0043 respectively). These data 
suggest that FRG1 over-expression might interfere with Suv4-20h1-dependent H4K20 
trimethylation of the Eid3 promoter, potentially resulting in its aberrant up-regulation. 
To investigate whether the lack of repression of Eid3 plays a role in the FRG1-associated 
phenotype, we down-regulated Eid3 expression in C2C12 cells over-expressing FRG1. Down-
regulation of Eid3 was able to significantly rescue the myogenic defect of FRG1 over-expressing 
cells compared to controls (Figure 8A-C; paired t test: p=0.0009, n=5). Collectively, our results 
suggest that the over-expression of FRG1 interferes with the repressive activity of Suv4-20h1 
leading to aberrant Eid3 up-regulation and myogenic defects. 
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DISCUSSION 
 
In this study, we focused on the largely unexplored role of FRG1 in muscle biology. We have 
recognized Suv4-20h1 as a direct FRG1 interactor and revealed that it is aberrantly localized upon 
FRG1 over-expression, suggesting that over-expression of FRG1 could interfere with Suv4-20h1 
function. Accordingly, the lack of Suv4-20h1 reproduced phenotypes similar to the FRG1 over-
expression while its over-expression ameliorates FRG1-associated myogenic defects. Altogether, 
these results suggest that the interference with Suv4-20h1 activity might play a relevant role in the 
myogenic defects associated to FRG1 over-expression. Notably, similar mechanisms might govern 
differentiation in other contexts. For example, it was recently reported that differentiation of 
postnatal spermatogonial progenitor cells (SPCs) is regulated by physical interaction and altered 
localization of the essential factors Sall4 and Plzf (Hobbs et al., 2012). Similarly to FRG1, Plzf is 
localized to euchromatic regions and nuclear speckles (Melnick et al., 2000). On the contrary, Sall4 
is associated with DAPI-dense pericentric heterochromatin like Suv4-20h1 (Sakaki-Yumoto et al., 
2006; Yamashita et al., 2007). When its expression increases in postnatal testis, Plzf binds Sall4 
sequestering it away from heterochromatin. This allows the expression of Sall1, a gene repressed by 
Sall4, and the inhibition of SPCs differentiation. Thus, it is tempting to speculate that the regulation 
of differentiation through altered localization of an heterochromatin-associated protein could be a 
more general mechanism used by other proteins. 
Suv4-20h1 has been traditionally considered to be involved in the structural maintenance of 
constitutive heterochromatin (Benetti, et al., 2007; Gonzalo, et al., 2005; Schotta, et al., 2004). 
Instead, our data show that Suv4-20h1 plays a relevant role in muscle biology and uncover a novel 
function for Suv4-20h1 as a gene-specific repressor required for myogenic differentiation. In 
particular, our results suggest that Eid3 (Bavner, et al., 2005) is a novel inhibitor of differentiation 
and a Suv4-20h1 target. We found that Eid3 expression is normally silenced upon induction of 
myogenic differentiation, but its silencing fails in C2C12 muscle cells over-expressing FRG1 or 
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knocked-down for Suv4-20h1. Based on our results, we propose that FRG1 over-expression might 
sequester Suv4-20h1 away from its epigenetic targets leading to their inappropriate de-repression 
(Figure 8D). Accordingly, we found that over-expression of FRG1 or Suv4-20h1 knockdown are 
both associated to an epigenetic de-regulation of the Suv4-20h1 enzymatic product, the repressive 
mark H4K20me3, at the Eid3 promoter. 
Despite its extensive study, FSHD pathogenesis remains unclear and controversial. All 
current models predict that deletion of D4Z4 repeats results in the de-regulation of a candidate 
gene(s), located in the FSHD region, leading to disease (Cabianca and Gabellini, 2010; van der 
Maarel et al., 2011). While the two most accepted FSHD candidate genes are DUX4 and FRG1, the 
molecular and cellular mechanism following their de-regulation and finally causing the disease 
remains elusive. Furthermore, FSHD is characterized by an extreme variability in disease onset, 
progression and severity. This heterogeneity in disease manifestation could reflect heterogeneity in 
gene expression of FSHD candidate gene(s). An interesting possibility, therefore, is that the 
complexity of FSHD could be explained envisaging that the epigenetic alteration of DUX4, FRG1 
and other potential genes could collaborate to determine the final phenotype. In this context, it is 
relevant to investigate the biological role of these players and address how each could contribute to 
the different aspects of the disease such as the muscle differentiation defects described in FSHD 
(Barro et al., 2005; Celegato et al., 2006; Tupler et al., 1999; Winokur, Barrett, et al., 2003; 
Winokur, Chen, et al., 2003). We found that Eid3 is up-regulated in affected muscles of FRG1 over-
expressing or Suv4-20h knockout mice and EID3 levels are inappropriately increased in biopsies of 
FSHD patients. Our results suggest that FRG1 and EID3 up-regulation areis not a general feature of 
muscular dystrophies but areis selectively found in FSHD patients when compared to other 
muscular dystrophy patients. Importantly, we have found that Eid3 over-expression causes muscle 
differentiation defects while its knockdown rescues the myogenic defects in FRG1 over-expressing 
cells. Overall, these data promote Eid3 a novel myogenic inhibitor that might explain, at least in 
part, the muscle differentiation defects associated to FRG1 over-expression. 
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MATERIALS AND METHODS 
 
Ethics Statement 
All procedures involving human samples were approved by the Fondazione San Raffaele del 
Monte Tabor Ethical Committee. All animal procedures were approved by the Institutional Animal 
Care and Use Committee of the Fondazione San Raffaele del Monte Tabor and were communicated 
to the Ministry of Health and local authorities according to Italian law. 
 
Yeast Two-Hybrid Screening 
MATCHMAKER two-hybrid system 3 (Clontech) was used for this study. DNA-BD/FRG1 
and AD/HeLa cDNA plasmid library (3.5x106 independent clones) were co-transformed in yeast 
and plated onto high stringency SD/–Ade/–His/–Leu/–Trp/3-AT/X-a-Gal plates. A total of 20x106 
clones were screened corresponding to a ~6 fold coverage of the HeLa cDNA library. AD/library 
plasmids were isolated from positive clones, rescued via transformation of E. coli and sequenced. In 
accordance with van Koningsbruggen et al. 2007, we identified Karyopherin alpha 2 (KPNA2) as 
first interactor with 30% of positive clones. SUV4-20H1 was the second protein identified with 
18.8% of positive clones. 
 
Constructs and cloning procedures 
All primers employed for cloning are listed in Supplementary Table I. PCR amplifications 
were performed with Pfx50 DNA polymerase (Invitrogen) or GoTaq polymerase (Promega). PCR 
products were digested with the restriction enzymes (Takara) listed in Supplementary Table I and 
ligated into the respective destination plasmid with T4 ligase (Fermentas). pCMV-HA and pCMV-
Myc (Clontech) were employed for mammalian transient expression, while pRSET-A (Invitrogen) 
and pGEXT2T (GE Healthcare) for protein production in E. coli. For pCMV-myc-FRG1, FRG1 
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coding sequence was excised with PstI from pGBKT7-FRG1, blunted with T4 DNA polymerase 
(Fermentas) and then digested with SfiI to release the insert. pCMV-myc (Clontech) was digested 
with XhoI, blunted with Klenow Fragment of DNA polymerase (Fermentas) and digested with SfiI. 
pDEST15GW-Suv4-20h1, pGEX-6P1GW-Suv4-20h1(385-874aa) and pEGFP-N1-Suv4-20h1 were 
previously described (Schotta, et al., 2004). pLKO.1 lentiviral vectors expressing control shRNA or 
specific shRNAs for Suv4-20h1 and packaging constructs were purchased from Open Biosystems. 
pBABE-SUV4-20H1_ERα plasmid was a kind gift of Dr. Holger Bierhoff (German Cancer Research 
Center, Heidelberg, Germany). For pIRESneo3-HA-Eid3 (pH-Eid3), Eid3 was first amplified from 
C2C12 cDNA with the primers listed in Supplementary Table I and cloned into pCMV-HA 
(Clontech). The HA-Eid3 sequence was then excised with StuI and NotI and ligated into pIRESneo3 
(Clontech) previously digested with the same enzymes. 
 
Proteins purification 
6xHis-FRG1 and GST-Suv4-20h1 proteins were expressed in Rosetta2(DE3)pLys E.coli 
(Novagen). Protein expression was induced at 0.4-0.6 OD with 1mM IPTG (Biosciences) for 3h at 
37°C (or 8h at 30°C for GST-Suv4-20h1 full-length). Bacterial pellets were resuspended in PBS 
and Protease Inhibitor cocktail (PI; Sigma) or in Lysis Buffer (50mM NaH2PO4, 250 mM NaCl, pH 
8.0, plus PI) for GST- and His-tagged proteins, respectively. Bacteria were lyzed by sonication 
(Bandelin), incubated by gentle rotation for 15 min at 4°C, after adding TritonX100 (1%; Sigma), 
and centrifuged at 19.000 rpm at 4°C for 20 min. Supernatants were incubated for 1 h at 4°C in 
batch with Glutathione-Agarose beads (Sigma) or HIS-Select Nickel Affinity gel beads (Sigma). 
Beads were packed on a disposable column and washed by gravity flow with 50 beads volumes of 
PBS-TritonX100 (1%) plus PI or Lysis buffer supplemented with 10mM Imidazole (Fluka), for 
GST and His-tagged proteins respectively. Proteins were eluted with 50 mM Tris-HCl pH 9.0, 10 
mM Reduced L-Glutathione (Sigma) plus PI or 50mM NaH2PO4, 250 mM NaCl, 250 mM of 
Imidazole, pH 8.0 plus PI, for GST and His-tagged proteins respectively. Proteins were dialyzed 
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overnight at 4°C in dialysis cassettes (Slide-A-Lyzer Dialysis Cassettes; Thermo scientific) in 50 
mM Tris-HCl, pH 9.0 or in 50mM NaH2PO4, 250 mM NaCl, pH 8.0, for GST- and His-tagged 
proteins respectively. After dialysis, glycerol was added to His-tagged proteins to a 10% final 
concentration. 
 
Co-immunoprecipitation assays 
For figure 1A, HEK293T cells were transfected with pCMV-Myc-FRG1. For figures S1A 
and S1B, HEK293T cells were co-transfected with pCMV-HA-SUV4-20H1/pCMV-HA-Suv4-
20h1(509-630)/pCMV-HA or pEGFP-N1-Suv4-20h1/pEGFP-N3 and pCMV-Myc-FRG1/pCMV-
Myc with Lipofectamine LTX (Invitrogen) according to manufacturer’s instructions, plasmids were 
transfected in a 1:1 ratio. Cells were collected after 36h from transfection. Co-immunoprecipitation 
(co-IP) assays were performed as described in (van Koningsbruggen, et al., 2007) with  mouse anti-
HA clone 16B12 (MMS-101R, Covance), or rabbit anti-GFP (A11122, Molecular Probes), rabbit 
anti-SUV4-20H1 (LS-C161629, Lifespan Bioscience) or rabbit IgG (#011-000-003, Jackson 
Immunoresearch). Input (0.1% or 3%) and Bound (20%) fractions of the co-IP were analyzed by 
SDS-PAGE followed by immunoblotting with the above-mentioned primary antibodies at 1/500 
dilution for anti-SUV4-20H1 and 1/1000 dilution anti-HA, anti-GFP and mouse anti-c-Myc clone 
9E10 (MMS-150R Covance).  and aAnti-mouse and anti-rabbit IgG HRP-conjugated secondary 
antibody (#715-035-150 and #711-035-152, Jackson ImmunoResearch; dilution: 1/20000) 
secondary antibodies were used. 
 
GST and Histidine pull-down assays 
Pull-down assays were performed by incubating, overnight at 4°C, equal molar amounts (10 
to 50 picomoles) of GST-tagged with His-tagged proteins in cold CHAPS buffer [50 mM Tris-HCl 
pH 7.4, 150 mM NaCl, 0.15% CHAPS (3-[(3-Cholamidopropyl) dimethylammonio]-1-
propanesulfonate; Fluka) and Protease Inhibitor Cocktail (Sigma) plus 5mM Imidazole for His pull-
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downs (van Koningsbruggen, et al., 2007). 20 µl of beads slurry were added and incubated for 1 h at 
4°C and then washed 4 times with 1 ml cold CHAPS buffer, one time with 1 ml cold 50 mM Tris-
HCl pH 7.4 plus PI and boiled in 50 µl of 1X Laemmli buffer at 95°C for 8 min. Input (1%) and 
Bound (20%) fractions were analyzed by immunoblotting with mouse anti-GST (G1160, Sigma; 
dilution: 1/10000) mouse anti-6xHis (#631212, Clontech; dilution: 1/5000,) and anti-mouse IgG 
HRP-conjugated secondary antibody (#715-035-150, Jackson ImmunoResearch; dilution: 1/20000). 
 
FRG1 and SUV4-20H1 localization analysis 
C2C12 cells were seeded on glass coverslips and were co-transfected 24h later with pCMV-
Myc-FRG1 or pCMV-Myc and pEGFP-C1-SUV4-20H1_i1, pEGFP-C1-SUV4-20H1_i2, pEGFP-
C1-SUV4-20H2, kindly provided by Alan Underhill (University of Alberta, Canada) (Tsang, et al., 
2010) or pEGFP-N3 (Clontech) with Lipofectamine LTX (Invitrogen) according to manufacturer’s 
instructions. Plasmids were transfected in a 1:1 ratio (500ng each). Cells were fixed in 4% 
paraformaldehyde (Electron Microscopy Science) 36h post transfection. Immunofluorescence was 
performed with mouse anti-c-Myc clone 9E10 (MMS-150R Covance; dilution 1/5000). Alexa Fluor 
555 goat anti-mouse (Molecular Probes, 1/500) was used for secondary detection. Samples were 
mounted in aqueous medium and acquired at room temperature, using a Deltavision Restoration 
Microscopy System (Applied Precision) built around an Olympus IX70 microscope equipped with 
mercury-arc illumination CoolSnap_Hq/ICX285 CCD camera. 0.1µm sections were collected with 
an Olympus 60X/1.4 NA Plan Apo oil immersion objective lens and deconvolved with SoftWoRx 
3.5.0 (Applied Precision) by the constrained iterative algorithm using 10 iterations and standard 
parameters. Representative pictures of three independent experiments are shown. 
 
Drosophila Position Effect Variegation analysis 
Flies were raised at 25°C on K12 Medium (USBiological). All crosses were conducted at 
25°C. Suv4-20BG00814 (Bloomington, stock # 12510), UAS-FRG1RNAi (Vienna Drosophila RNAi 
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Stock center, stock # v23447), w1118 (Bloomington, stock # 3605) and T(2;3)SbV⁄TM3,Ser (kindly 
provided by Sergio Pimpinelli) fly strains were employed for this study. T(2;3)SbV translocation 
juxtaposes the Sb mutation and the centric heterochromatin of the second chromosome, resulting in 
a mosaic flies with both Sb and normal bristles. Activation of dominant Sb results in Stubble 
bristles. For Stubble (SbV) variegation analysis, ten pairs of major dorsal bristles of 20 flies were 
analyzed assigning a Sb- or Sb+ phenotype to each bristle. The extent of Sb variegation was 
expressed as the mean of Sb and WT bristles per strain. 
 
Immunofluorescence on Drosophila polytene chromosome spreads 
Larval salivary glands were dissected from third-instar larvae grown at 25°C. 
Immunofluorescence on polytene chromosome spreads were conducted as previously described 
(Burgio et al., 2008) with rabbit anti-H4K20me3 (ab9053, Abcam; dilution: 1/500). Images were 
acquired with a Leica DM 4000B microscope and densitometric analysis was performed with LAS 
AF Software (Leica). Quantification was carried out by calculating the intensity ratio between FITC 
(H4K20me3) and DAPI channels. Five chromosomal spreads were analyzed per strain. 
 
Cell lines generation, cell culture and differentiation 
HEK293T and Phoenix-Eco cells were cultured at 37°C in a 5% CO2 humidified incubator 
in DMEM supplemented with 10% FBS and 1% Penicillin/Streptomycin. C2C12 cells were 
cultured at 37°C in a 5% CO2, 5% O2 humidified incubator in DMEM supplemented with 10% FBS 
and 1% Penicillin/Streptomycin, plus 0.5 µg/µl G418 (Invivogen) for pFLAG-HA, pFLAG-HA-
FRG1 and pHA-Eid3 cells or plus 0.5 µg/ml puromycin (Invivogen) for pLKO.1 and pBABEpuro 
cells. 
pFH-FRG1 and pFH C2C12 cells were previously described (Gabellini, et al., 2006). 
pLKO.1 C2C12 cells expressing the non-silencing shRNA control or shRNAs specific for 
Suv4-20h1 were generated by lentiviral transduction of C2C12 cells according to manufacturer’s 
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instructions (Open Biosystems) and maintained as polyclonal populations under puromycin 
selection. 
pBABE-SUV4-20H1_ERα/pFH-FRG1 over-expressing C2C12 cells were generated by 
retroviral transduction of pFH-FRG1 myoblasts. Retroviral particles were prepared from Phoenix-
Eco cells (a gift from Dr. Gary P. Nolan) following the Nolan Laboratory protocol 
(http://www.stanford.edu/group/nolan/protocols/pro_helper_dep.html). Transduced cells were 
subjected to double G418 (0.5 µg/µl) and Puromycin (0.5 µg/ml) selection. Resistant cells were 
maintained as polyclonal population and grown under constant selection. The translocation of 
SUV4-20H1_ERα to the nucleus was induced with 500nM 4-hydroxytamoxifen (4-OHT) treatment 
(H7904, Sigma) for 72h prior to differentiation; 4-OHT was maintained during differentiation. 
pH-Eid3 cells were generated by transfecting C2C12 cells with linearized pH-Eid3 or pFH 
using Lipofectamine LTX (Invitrogen) according to the manufacturer's instructions, 48h later, 0.5 
µg/µl G418 was added to the media. G418-resistant cells were maintained as a pool and grown 
under constant selection. 
Eid3 knock-down/pFH-FRG1 over-expressing C2C12 cells were generated by transfecting 
pFH-FRG1 myoblasts with 50nM siRNAs against Eid3 (L-046381-01, ON-TARGETplus 
SMARTpool, Mouse 1700027M21RIK, Thermo Scientific) or non-silencing control (D-001810-10, 
ON-TARGETplus Non targeting pool, Thermo Scientific) following manufacturer’s instructions. 
Transfections were performed 72h prior to differentiation. 
Proteins over-expression and down-regulation were evaluated by immunoblotting with 
mouse anti-FRG1 (sc-101050, Santa Cruz; dilution 1/500) for pFH-FRG1, mouse anti-HA clone 
16B12 (MMS-101R, Covance; dilution 1/500) for pFH-FRG1 and for pH-Eid3, rabbit anti-SUV4-
20H1 (ab18186, Abcam; dilution 1/1000) for pLKO.1 Suv4-20h1 knockdown cells, rabbit anti-ERα 
(sc-543, Santa Cruz, dilution 1/500) for pBABE-SUV4-20H1_ERα over-expressing cells, mouse 
anti-Tubulin (T9026, Sigma; dilution 1/400000) for normalization and anti-mouse or anti-rabbit 
Page 21 of 54
http://mc.manuscriptcentral.com/jmcb
Manuscripts submitted to Journal of Molecular Cell Biology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
IgG HRP-conjugated for secondary detection (#715-035-150 and #711-035-152, Jackson 
ImmunoResearch; dilution: 1/20000). 
Global levels of H4K20me3 in FRG1 over-expressing and Suv4-20h1 knock-down cells 
(myoblasts and myotubes at 3 days of differentiation) were evaluated by immunoblot with rabbit 
anti-H4-20me3 (kindly provided by Dr. Thomas Jenuwein, dilution 1/300) and rabbit anti-H4 (#62-
141-13, Millipore; dilution 1/3000). Histone extracts were obtained following the histone extraction 
protocol from Abcam (http://www.abcam.com/index.html?pageconfig=resource&rid=11410). 
For differentiation experiments, C2C12 cells were plated at confluence in collagen-coated 
dishes and were differentiated for 3 days in DMEM containing 2% donor horse serum (EuroClone). 
For Fusion index quantification, cells were fixed in 4% paraformaldehyde (Electron 
Microscopy Science) and immunostained with mouse MF20 antibody (Developmental Studies 
Hybridoma Bank; dilution: ½) followed by Alexa Fluor 488 goat anti-mouse (Molecular Probes, 
1/500) and Hoechst (1mg/ml; Sigma; dilution: 1/2000). Samples were visualized at room 
temperature, using Observer.Z1 (N-Achroplan 10x/0.25 NA Ph1) microscope (Zeiss). Pictures were 
acquired with a AxioCam MRm camera using its AxioVision Rel. 4.8.2 software by Nikon. Fusion 
Index analysis was performed with ImageJ by counting the number of nuclei belonging or not to 
myotubes. Myotubes are considered as myosin positive syncytia containing at least 3 nuclei. A 
minimum of three independent differentiation experiments were performed, for each experiment at 
least 6 fields were analyzed, counting at least 1000 nuclei for each cell type. 
 
Human samples.  
Muscle biopsies from FSHD and BMD patients and healthy controls were obtained from the 
Italia Telethon Network of Genetic Biobanks (http://www.biobanknetwork.org)Neuromuscular 
Bank of the Department of Neurosciences, University of Padova, Italy. Detailed information 
regarding the individual samples is provided in Supplementary Table II. 
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Mouse handling 
FRG1-high mice (Gabellini, et al., 2006) and control C57BL/6J littermates were maintained 
at Charles River (Calco, Italy). To obtain muscle-specific Suv420h1-/-_Suv420h2-/- double knockout 
mice, Suv420h1-/flox and Suv420h2-/- mice (Schotta, et al., 2008) were bred with HSA-cre mice, in 
which the cre recombinase gene is driven by the human alpha-skeletal actin (HSA) promoter. Mice 
at 3–18 weeks of age were sacrificed for this study. 
 
Primary muscle cell cultures and Muscle Histology 
Cell preparations were obtained by vastus lateralis muscles of four weeks-old males as 
previously described (Xynos et al., 2011) and were plated on collagen-coated dishes after pre-
plating for 1 hour in uncoated dishes. Primary myoblasts were grown in nutrient mixture F-10 Ham 
(Sigma) supplemented with 20% FBS (Hyclone) and 5ng/ml bFGF (Peprotech) for 1–5 days and 
differentiated in Dulbecco’s modified Eagle medium (DMEM; EuroClone) supplemented with 5% 
donor horse serum (EuroClone) for 1–2 days. Vastus lateralis and tibialis anterior muscles were 
dissected, frozen in isopentane cooled in liquid nitrogen and cryosectioned (8-µm thick). Gomori-
trichrome staining was performed as previously described (Dubowitz, 1985; Xynos, et al., 2011). 
For H4K20me3 immunofluorescence, tissue sections were fixed in 4% PFA for 10 min at RT and 
incubated with rabbit anti-H4K20me3 (ab9053, Abcam; dilution: 1/200). Images were visualized 
with Imager.M2 (N-Achroplan 20x/0.45 NA) and pictures were acquired with AxioCamMRc5 
camera. 
 
Real-time PCR analysis 
Total RNA from primary cells and tissues was extracted and treated with DNase 1, using the 
RNAqueous-4PCR kit (Ambion) and RNeasy Fibrous Tissue Midi or Mini Kit (Qiagen), 
respectively. cDNA was synthesized using Invitrogen’s SuperScript III First-Strand Synthesis 
Super-Mix. Genomic DNA was extracted with DNeasy Blood & Tissue Kit (Qiagen). qPCRs (for 
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primers see supplementary table III) were performed with SYBR GreenER qPCR SuperMix 
Universal (Invitrogen) using Biorad’s CFX96 Real-time System. Relative quantification was 
calculated with CFX Manager Software V.1.6. Validation of the differential expression of genes 
identified by DNA microarray was performed using TaqMan gene expression assays with custom-
made TaqMan array microfluidic cards (Applied Biosystems). Relative quantification was 
calculated with qBasePLUS V.1.5 using Gapdh, Ppia and 18S rRNA as reference genes. 
 
Chromatin Immunoprecipitation 
Cells were briefly washed once in PBS and fixed for 10 minutes in 1% formaldehyde in 
PBS (from a 37.5% formaldehyde/10% methanol stock). After formaldehyde quenching with 
Glycine (final concentration 125 mM) for 5 minutes, cells were washed with PBS, harvested by 
scraping and pelleted. The pellet was lysed in a solution containing 50 mM Hepes-KOH pH 7.5, 
140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP40 and 0.25% Triton X100 for 10 minutes in 
ice. Nuclei were pelleted and subsequently lysed in a solution containing 10 mM Tris-HCl pH 8.0, 
200 mM NaCl, 1 mM EDTA and 0.5 mM EGTA with gentle swirl for 10 minutes. Next, samples 
were centrifuged and the resulting pellet was resuspended in a solution with 10 mM Tris-HCl pH 
8.0, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% Na-Deoxycholate and 0.5% N-
laurylsarcosine. Chromatin was sheared by sonication using Bioruptor (Diagenode) and Triton 
X100 was added to lysates at a final concentration of 1%. 10 µg of chromatin were used for each 
immunoprecipitation and pre-cleared for 3 hours at 4°C with 20 µl of Protein G dynabeads 
(Invitrogen). Immunoprecipitations were carried out at 4°C overnight with 50 µl of beads 
previously bound for 3 hours at 4°C with 5 µg of the following antibodies: rabbit anti-H4 (#62-141-
13, Millipore), rabbit anti-H4K20me3 (pAb-057-050, Diagenode) and whole molecule rabbit IgG 
(#011-000-003, Jackson Immunoresearch). Immunoprecipitated chromatin was washed extensively 
with a solution containing 50 mM Hepes-KOH pH 7.6, 500 mM LiCl, 1 mM EDTA, 1% NP-40 and 
0.7% Na-Deoxycholate, and protein–DNA cross-links were reverted by heating at 65°C overnight 
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in TE buffer with 2% SDS. DNA was purified with QIAquick PCR Purification Kit (Qiagen) and 
qPCRs were performed using a custom-made ChampionChIP PCR Array (SABiosciences) in 
Applied Biosystems ViiA 7 Real-Time PCR System. 
 
Statistical analysis 
All statistical analyses were two-tailed tests and performed using GraphPad Prism version 
5.0a (GraphPad Software, San Diego, USA). The type of statistical test, p value, number of 
independent experiments, mean and standard error of the mean are provided for each data set in the 
corresponding figure legends. 
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FIGURE LEGENDS 
 
Figure 1. FRG1 directly interacts with the histone methyltransferase Suv4-20h1. (A) Co-
immunoprecipitation with anti-SUV4-20H1HA shows that Myc-FRG1 interacts with HA-SUV4-
20H1. Immunoblots for Myc and HASUV4-20H1. (B) Co-immunoprecipitation with anti-GFP 
shows that Myc-FRG1 interacts with GFP-Suv4-20h1. Immunoblots for Myc and GFP. (C) GST 
pull-down assay demonstrates that FRG1 interacts directly with the C-terminus of Suv4-20h1. 
Recombinant 6xHis-FRG1 was specifically pulled down by GST-Suv4-20h1 full length and 385-
874. Immunoblot for 6xHis. (DC) Schematic representation of Suv4-20h1 truncation constructs. 
(ED) His pull-down demonstrates that FRG1 interacts directly with the Suv4-20h1(509-630). 
Immunoblot for GST. Multiple bands in the first two lanes of the blots correspond to degradation 
products of Suv4-20h1 (FE) Co-immunoprecipitation with anti-HA shows that Myc-FRG1 co-
immunoprecipitates with Suv4-20h1(509-630). Immunoblots for Myc and HA. 
 
Figure 2. FRG1 over-expression alters the sub-nuclear distribution of SUV4-20H1.1. 
(A-D) GFP fluorescence and immunofluorescence for Myc of C2C12 myoblasts transiently 
transfected with pCMV-Myc-FRG1 or pCMV-Myc (in red) and pEGFP-C1-SUV4-20H1.1(A), 
pEGFP-C1-SUV4-20H1.2 (B), pEGFP-C1-SUV4-20H2 (C) or pEGFP-N3 (D) (in green). 
Deconvoluted 0.1 µm sections at 60x magnification. Scale bars, 5 µm.  
 
Figure 3. FRG1 over-expression or Suv4-20h1 knockdown inhibit muscle differentiation in 
C2C12 cells. Immunofluorescence for Myosin heavy chain (Mhc) (A) and fusion index analysis (C) 
shows that pFH-FRG1 over-expressing cells display a significant decrease in the fusion index 
compared to control (pFH) (paired t test: p=0.0067, n=3) and untreated C2C12 cells (paired t test: 
p=0.0067, n=3). Mean ± SEM are shown. Immunofluorescence for Myosin heavy chain (Mhc) (B) 
and fusion index analysis (D) shows that Suv4-20h1 knockdown (shRNA#1, 2 and 3) cells display a 
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significantly reduced myogenic differentiation compared to control shRNA expressing cells (one-
way Anova test: p<0.0001, n=3, mean ± SEM). (E) Immunoblot performed on pFH and pFH-FRG1 
myoblasts (anti-FRG1, anti-HA and anti-Tubulin). (F) Immunoblot performed on control shRNA 
and Suv4-20h1 shRNA#1, 2 and 3 myoblasts (anti-Suv4-20h1 and anti-Tubulin. Scale bars, 200 
µm. 
 
Figure 4. SUV4-20H1 over-expression partially rescues FRG1 phenotype. Immunofluorescence 
for Myosin heavy chain (Mhc) (A) and fusion index analysis (B) show that 4-hydroxytamoxifen (4-
OHT) induction of SUV4-20H1_ERα/pFH-FRG1 cells leads to a specific and significant 
amelioration of the differentiation of FRG1 over-expressing myotubes compared to control cells 
(two way Anova test, p= 0.0406; n=3, mean ± SEM) (C) Immunoblot performed in SUV4-
20H1_ERα/pFH-FRG1 and empty vector control/pFH-FRG1 myoblasts (anti-ERα and anti-
Tubulin). Scale bars, 200 µm. 
 
Figure 5. Partial muscle-specific Suv4-20h knockout causes muscular dystrophy signs. (A) 
qPCR analysis for the Suv4-20h1flox allele in Suv4-20h1flox/- mice Cre+ or Cre- shows that the Suv4-
20h1flox allele is not completely excised in muscles from Suv4-20h1-/- mice (n≥4, mean ± SEM). (B) 
qRT-PCR analysis for Suv4-20h1 in Suv4-20h1flox/- mice Cre+ or Cre- displays a partial Suv4-20h1 
reduction in muscles from Suv4-20h1-/- mice (n≥4, mean ± SEM). (C) Immunofluorescence for 
H4K20me3 of tibialis anterior transverse cryosections from four-months old mice. (DA–FC) 
Gomori-trichrome staining of tibialis anterior transverse cryosections (AD). mDKO mouse muscles 
contain significantly more necrotic (EB; Mann-Whitney test: p=0.0079, n=5) and centrally-
nucleated (C; Mann-Whitney test: p=0.0079, n=5) myofibers than WT controls. Error bars represent 
the standard error of the means of five animals. Scale bars, 100 µm. 
 
Page 33 of 54
http://mc.manuscriptcentral.com/jmcb
Manuscripts submitted to Journal of Molecular Cell Biology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Figure 6. Eid3 is down-regulated upon muscle differentiation and behaves as myogenic 
inhibitor gene. (A) qRT-PCR shows that WT primary myoblasts express significantly higher Eid3 
levels than myotubes (unpaired t test: p<0.0001, n=3, mean ± SEM). (B) qRT-PCR for Eid3 
performed in C2C12 myoblasts and myotubes shows that C2C12 myoblasts express significantly 
higher levels of Eid3 compared to myotubes (one sample t test: p=0.0052, n=3, mean ± SEM). (C) 
Immunofluorescence for Myosin Heavy Chain (Mhc) and (D) fusion index analysis shows that pH-
Eid3 over-expressing cells display a significantly decreased fusion index compared to control (pFH) 
(paired t test: p=0.0057, n=3, mean ± SEM). (E) Immunoblot performed on pFH and pH-Eid3 
myoblasts (anti-HA and anti-Tubulin). 
 
Figure 7. The myogenic inhibitor gene Eid3 is specifically over-expressed in FSHD and is an 
FRG1/Suv4-20h1 target. (A–F) qRT-PCR for Eid3 in several biological samples. Eid3 is 
significantly up-regulated in vastus from asymptomatic three-weeks old FRG1 mice (A; paired t 
test: p=0.0039, n=5, mean ± SEM) compared to WT controls. Eid3 levels are significantly increased 
in C2C12 muscle cells over-expressing FRG1 (B; one sample t test: p=0.0025, n=4, mean ± SEM) 
compared to empty vector controls. Eid3 expression is preferentially altered in severely affected 
muscles (vastus lateralis) compared to mildly affected muscles (biceps brachii) (C, paired t test: 
p=0.0086, n=3, mean ± SEM). Eid3 is significantly more abundant in mDKO mice than WT controls 
(D; unpaired t test: p=0.0019, n=5, mean ± SEM). Eid3 is significantly up-regulated in C2C12 
muscle cells knockdown for Suv4-20h1 (E; one sample t test: p=0.0039, n=4, mean ± SEM) 
compared to non-silencing control cells. EID3 levels are significantly increased in FSHD muscle 
biopsies compared to healthy and otherBecker muscular dystrophy controls (F; one-way Anova test: 
p=0.0029485, n=73–84, mean ± SEM). (G) qRT-PCR for FRG1 in several human muscle biopsies. 
FRG1 is specifically over-expressed in FSHD patients compared to healthy and other muscular 
dystrophy controls (one-way Anova test: p=0.0013, n=7–8, mean ± SEM). (H) Pearson correlation 
analysis shows that FRG1 and EID3 expression levels are highly correlated (R2=0.6611; p<0.0001, 
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n=22) (IG-JH) Chromatin immunoprecipitation, using total H4, H4K20me3 and IgG, as control 
antibodies. H4K20me3 is significantly reduced at the Eid3 genomic region spanning -6 to -2 kb 
from TSS in FRG1 over-expressing (G; two-way Anova test: p=0.0099, representative experiment, 
mean ± SEM) and Suv4-20h1 knockdown (H; two-way Anova test: p=0.0043, representative 
experiment, mean ± SEM) C2C12 myotubes. H4K20me3 and IgG levels are relative to H4 and 
normalized by the H4K20me3 -6kb region enrichment levels of control samples (pFH and non 
silencing respectively). 
 
Figure 8. Eid3 knockdown rescues the myogenic capability of FRG1 over-expressing cells. 
Immunofluorescence for Myosin Heavy Chain (Mhc) (A) and fusion index analysis (B; paired t test: 
p=0.0009, n=5, mean ± SEM) show that Eid3 knockdown significantly ameliorates the 
differentiation capability of pFH-FRG1 over-expressing cells (Eid3 siRNA) compared to non-
silencing control (control siRNA). (C) qRT-PCR analysis for Eid3 in pFH-FRG1/Eid3 siRNA 
displays a partial Eid3 knockdown compared to pFH-FRG1/control siRNA (paired t test: p=0.0016, 
n=5, mean ± SEM). Scale bars, 200 µm. (D) Graphical representation of FRG1-overexpression 
proposed model. 
 
Figure S1. FRG1 interacts with the murine and human histone methyltransferase Suv4-20h1. 
(A) Co-immunoprecipitation with anti-HA shows that Myc-FRG1 interacts with HA-SUV4-20H1. 
Immunoblots for Myc and HA. (B) Co-immunoprecipitation with anti-GFP shows that Myc-FRG1 
interacts with GFP-Suv4-20h1. Immunoblots for Myc and GFP. 
 
Figure S12. The genetic interaction between FRG1 and Suv4-20h1 is evolutionarily conserved. 
(A) Stubble Position effect variegation (PEV) analysis performed in T(2;3)SbV/TM3,Ser (SbV) 
shows that Act5CGAL4;UAS-FRG1RNAi/T(2;3)SbV (FRG1RNAi/SbV) flies display a decreased number 
of Stubble bristles compared to control T(2;3)SbV/TM3,Ser (SbV) flies (Fisher exact test: p<0.0001, 
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n=400 from 20 flies) as opposed to Suv4-20BG00814/T(2;3)SbV (Suv4-20BG00814/SbV) flies (Fisher 
exact test: p<0.0001, n=400 from 20 flies). Error bars represent the standard errors of the mean 
number of Stubble and WT bristles of 20 flies. (B) Representative image of Stubble (black arrow) 
and WT (green arrow) bristles. (C) Immunofluorescence for H4K20me3 of polytene chromosome 
spreads. (D) Densitometric analysis and quantification of H4K20me3 levels show that FRG1RNAi 
flies display significantly increased levels of H4K20me3 compared to control w1118 flies (unpaired 
t test: p<0.0001, n=5) as opposed to Suv4-20BG00814 (unpaired t test: p<0.0001, n=5), mean ± SEM 
are shown. 
 
Figure S32. H4K20me3 levels are unaltered in FRG1 over-expressing cells and slightly 
reduced in Suv4-20h1 knock-down C2C12 cells. Immunoblot for H4K20me3 and total H4 in 
protein extracts from FRG1 over-expressing cells and Suv4-20h1 knock-down cells and their 
relative controls at the myoblast and myotube stage. 
Suv4-20h1 Excision rate and expression analysis in Suv4-20h mDKO mouse (A) qPCR analysis 
for the Suv4-20h1flox allele in Suv4-20h1flox/- mice Cre+ or Cre- shows that the Suv4-20h1flox allele is 
not completely excised in muscles from Suv4-20h1-/- mice (n≥4, mean ± SEM). (B) qRT-PCR 
analysis for Suv4-20h1 in Suv4-20h1flox/- mice Cre+ or Cre- displays a partial Suv4-20h1 reduction 
in muscles from Suv4-20h1-/- mice (n≥4, mean ± SEM). (C) Immunofluorescence for H4K20me3 of 
tibialis anterior transverse cryosections from four-months old mice. Scale bars, 100 µm 
 
Figure S43. qRT-PCR validation of differentially expressed genes in vastus muscles from pre-
dystrophic, four-week-old WT and FRG1 over-expressing mice. A selection of 56 differentially 
expressed genes obtained by Microarray analysis was validated using qRT-PCR. A heatmap of log2 
fold change microarrays results (rigth side) and the corresponding log2 fold change qRT-PCR 
validation on independent animals (left side). Relative quantification for qRT-PCRs has been 
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calculated using qbasePLUS software and the relative quantification mean from 3 WT mice has 
been used for each ratio calculation. 
 
Figure S5. EID3 and FRG1 are specifically over-expressed in FSHD compared to healthy 
subjects and other muscular dystrophy controls. (A-D) Scattered plots of qRT-PCR performed 
in human muscle biopsies samples from heathy subjects, FSHD patients and other muscular 
dystrophy patients. (A) qRT-PCR for EID3 shows significant over-expression in FSHD compared 
to controls (one-way Anova: p=0.0029, n=7-8, mean ± SEM). (B) qRT-PCR for FRG1 shows 
significant over-expression in FSHD compared to controls (one-way Anova: p=0.0013, n=7-8, 
mean ± SEM). (C) qRT-PCR for SUV4-20H1 shows that SUV4-20H1 levels are not significantly 
different in FSHD muscle compared to healthy and other muscular dystrophy controls (one-way 
Anova test: p=ns, n=7–8, mean ± SEM). (D) qRT-PCR for β-glucuronidase (GUS) shows that 
SUV4-20H1 levels are not significantly different in FSHD muscle compared to healthy and other 
muscular dystrophy controls (one-way Anova test: p=ns, n=7–8, mean ± SEM). 
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FRG1 directly interacts with the histone methyltransferase Suv4-20h1. (A) Co-immunoprecipitation with 
anti-SUV4-20H1 shows that Myc-FRG1 interacts with SUV4-20H1. Immunoblots for Myc and SUV4-20H1. 
(B)  GST pull-down assay demonstrates that FRG1 interacts directly with the C-terminus of Suv4-20h1. 
Recombinant 6xHis-FRG1 was specifically pulled down by GST-Suv4-20h1 full length and 385-874. 
Immunoblot for 6xHis. (C) Schematic representation of Suv4-20h1 truncation constructs. (D) His pull-down 
demonstrates that FRG1 interacts directly with the Suv4-20h1(509-630). Immunoblot for GST. Multiple 
bands in the first two lanes of the blots correspond to degradation products of Suv4-20h1 (E) Co-
immunoprecipitation with anti-HA shows that Myc-FRG1 co-immunoprecipitates with Suv4-20h1(509-630). 
Immunoblots for Myc and HA.  
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FRG1 over-expression alters the sub-nuclear distribution of SUV4-20H1.1.  
(A-D) GFP fluorescence and immunofluorescence for Myc of C2C12 myoblasts transiently transfected with 
pCMV-Myc-FRG1 or pCMV-Myc (in red) and pEGFP-C1-SUV4-20H1.1(A), pEGFP-C1-SUV4-20H1.2 (B), 
pEGFP-C1-SUV4-20H2 (C) or pEGFP-N3 (D) (in green). Deconvoluted 0.1 µm sections at 60x magnification. 
Scale bars, 5 µm.  
171x235mm (300 x 300 DPI)  
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FRG1 over-expression or Suv4-20h1 knockdown inhibit muscle differentiation in C2C12 cells. 
Immunofluorescence for Myosin heavy chain (Mhc) (A) and fusion index analysis (C) shows that pFH-FRG1 
over-expressing cells display a significant decrease in the fusion index compared to control (pFH) (paired t 
test: p=0.0067, n=3) and untreated C2C12 cells (paired t test: p=0.0067, n=3). Mean ± SEM are shown. 
Immunofluorescence for Myosin heavy chain (Mhc) (B) and fusion index analysis (D) shows that Suv4-20h1 
knockdown (shRNA#1, 2 and 3) cells display a significantly reduced myogenic differentiation compared to 
control shRNA expressing cells (one-way Anova test: p<0.0001, n=3, mean ± SEM). (E) Immunoblot 
performed on pFH and pFH-FRG1 myoblasts (anti-FRG1, anti-HA and anti-Tubulin). (F) Immunoblot 
performed on control shRNA and Suv4-20h1 shRNA#1, 2 and 3 myoblasts (anti-Suv4-20h1 and anti-
Tubulin. Scale bars, 200 µm.  
197x185mm (300 x 300 DPI)  
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SUV4-20H1 over-expression partially rescues FRG1 phenotype. Immunofluorescence for Myosin heavy chain 
(Mhc) (A) and fusion index analysis (B) show that 4-hydroxytamoxifen (4-OHT) induction of SUV4-
20H1_ERα/pFH-FRG1 cells leads to a specific and significant amelioration of the differentiation of FRG1 over-
expressing myotubes compared to control cells (two way Anova test, p= 0.0406; n=3, mean ± SEM) (C) 
Immunoblot performed in SUV4-20H1_ERα/pFH-FRG1 and mpty vector control/pFH-FRG1 myoblasts (anti-
ERα and anti-Tubulin). Scale bars, 200 µm.  
172x121mm (300 x 300 DPI)  
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Partial muscle-specific Suv4-20h knockout causes muscular dystrophy signs. (A) qPCR analysis for the Suv4-
20h1flox allele in Suv4-20h1flox/- mice Cre+ or Cre- shows that the Suv4-20h1flox allele is not completely 
excised in muscles from Suv4-20h1-/- mice (n≥4, mean ± SEM). (B) qRT-PCR analysis for Suv4-20h1 in 
Suv4-20h1flox/- mice Cre+ or Cre- displays a partial Suv4-20h1 reduction in muscles from Suv4-20h1-/- 
mice (n≥4, mean ± SEM). (C) Immunofluorescence for H4K20me3 of tibialis anterior transverse 
cryosections from four-months old mice. (D–F) Gomori-trichrome staining of tibialis anterior transverse 
cryosections (D). mDKO mouse muscles contain significantly more necrotic (E; Mann-Whitney test: 
p=0.0079, n=5) and centrally-nucleated (C; Mann-Whitney test: p=0.0079, n=5) myofibers than WT 
controls. Error bars represent the standard error of the means of five animals. Scale bars, 100 µm.  
209x297mm (300 x 300 DPI)  
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Eid3 is down-regulated upon muscle differentiation and behaves as myogenic inhibitor gene. (A) qRT-PCR 
shows that WT primary myoblasts express significantly higher Eid3 levels than myotubes (unpaired t test: 
p<0.0001, n=3, mean ± SEM). (B) qRT-PCR for Eid3 performed in C2C12 myoblasts and myotubes shows 
that C2C12 myoblasts express significantly higher levels of Eid3 compared to myotubes (one sample t test: 
p=0.0052, n=3, mean ± SEM). (C) Immunofluorescence for Myosin Heavy Chain (Mhc) and (D) fusion index 
analysis shows that pH-Eid3 over-expressing cells display a significantly decreased fusion index compared to 
control (pFH) (paired t test: p=0.0057, n=3, mean ± SEM). (E) Immunoblot performed on pFH and pH-Eid3 
myoblasts (anti-HA and anti-Tubulin).  
171x147mm (300 x 300 DPI)  
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The myogenic inhibitor gene Eid3 is specifically over-expressed in FSHD and is an FRG1/Suv4-20h1 target. 
(A–F) qRT-PCR for Eid3 in several biological samples. Eid3 is significantly up-regulated in vastus from 
asymptomatic three-weeks old FRG1 mice (A; paired t test: p=0.0039, n=5, mean ± SEM) compared to WT 
controls. Eid3 levels are significantly increased in C2C12 muscle cells over-expressing FRG1 (B; one sample 
t test: p=0.0025, n=4, mean ± SEM) compared to empty vector controls. Eid3 expression is preferentially 
altered in severely affected muscles (vastus lateralis) compared to mildly affected muscles (biceps brachii) 
(C, paired t test: p=0.0086, n=3, mean ± SEM). Eid3 is significantly more abundant in mDKO mice than WT 
controls (D; unpaired t test: p=0.0019, n=5, mean ± SEM). Eid3 is significantly up-regulated in C2C12 
muscle cells knockdown for Suv4-20h1 (E; one sample t test: p=0.0039, n=4, mean ± SEM) compared to 
non-silencing control cells. EID3 levels are significantly increased in FSHD muscle biopsies compared to 
healthy and other muscular dystrophy controls (F; one-way Anova test: p=0.0029, n=7–8, mean ± SEM). 
(G) qRT-PCR for FRG1 in several human muscle biopsies. FRG1 is specifically over-expressed in FSHD 
patients compared to healthy and other muscular dystrophy controls (one-way Anova test: p=0.0013, n=7–
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8, mean ± SEM). (H) Pearson correlation analysis shows that FRG1 and EID3 expression levels are highly 
correlated (R2=0.6611; p<0.0001, n=22) (I-J) Chromatin immunoprecipitation, using total H4, H4K20me3 
and IgG, as control antibodies. H4K20me3 is significantly reduced at the Eid3 genomic region spanning -6 to 
-2 kb from TSS in FRG1 over-expressing (G; two-way Anova test: p=0.0099, representative experiment, 
mean ± SEM) and Suv4-20h1 knockdown (H; two-way Anova test: p=0.0043, representative experiment, 
mean ± SEM) C2C12 myotubes. H4K20me3 and IgG levels are relative to H4 and normalized by the 
H4K20me3 -6kb region enrichment levels of control samples (pFH and non silencing respectively).  
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Eid3 knockdown rescues the myogenic capability of FRG1 over-expressing cells. Immunofluorescence for 
Myosin Heavy Chain (Mhc) (A) and fusion index analysis (B; paired t test: p=0.0009, n=5, mean ± SEM) 
show that Eid3 knockdown significantly ameliorates the differentiation capability of pFH-FRG1 over-
expressing cells (Eid3 siRNA) compared to non-silencing control (control siRNA). (C) qRT-PCR analysis for 
Eid3 in pFH-FRG1/Eid3 siRNA displays a partial Eid3 knockdown compared to pFH-FRG1/control siRNA 
(paired t test: p=0.0016, n=5, mean ± SEM). Scale bars, 200 µm. (D) Graphical representation of FRG1-
overexpression proposed model.  
193x121mm (300 x 300 DPI)  
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FRG1 interacts with the murine and human histone methyltransferase Suv4-20h1. (A) Co-
immunoprecipitation with anti-HA shows that Myc-FRG1 interacts with HA-SUV4-20H1. Immunoblots for Myc 
and HA. (B) Co-immunoprecipitation with anti-GFP shows that Myc-FRG1 interacts with GFP-Suv4-20h1. 
Immunoblots for Myc and GFP.  
183x98mm (300 x 300 DPI)  
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The genetic interaction between FRG1 and Suv4-20h1 is evolutionarily conserved. (A) Stubble Position effect 
variegation (PEV) analysis performed in T(2;3)SbV/TM3,Ser (SbV) shows that Act5CGAL4;UAS-
FRG1RNAi/T(2;3)SbV (FRG1RNAi/SbV) flies display a decreased number of Stubble bristles compared to 
control T(2;3)SbV/TM3,Ser (SbV) flies (Fisher exact test: p<0.0001, n=400 from 20 flies) as opposed to 
Suv4-20BG00814/T(2;3)SbV (Suv4-20BG00814/SbV) flies (Fisher exact test: p<0.0001, n=400 from 20 
flies). Error bars represent the standard errors of the mean number of Stubble and WT bristles of 20 flies. 
(B) Representative image of Stubble (black arrow) and WT (green arrow) bristles. (C) Immunofluorescence 
for H4K20me3 of polytene chromosome spreads. (D) Densitometric analysis and quantification of H4K20me3 
levels show that FRG1RNAi flies display significantly increased levels of H4K20me3 compared to control 
w1118 flies (unpaired t test: p<0.0001, n=5) as opposed to Suv4-20BG00814 (unpaired t test: p<0.0001, 
n=5), mean ± SEM are shown.  
171x171mm (300 x 300 DPI)  
 
 
Page 48 of 54
http://mc.manuscriptcentral.com/jmcb
Manuscripts submitted to Journal of Molecular Cell Biology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
H4K20me3 levels are unaltered in FRG1 over-expressing cells and slightly reduced in Suv4-20h1 knock-
down C2C12 cells. Immunoblot for H4K20me3 and total H4 in protein extracts from FRG1 over-expressing 
cells and Suv4-20h1 knock-down cells and their relative controls at the myoblast and myotube stage.  
104x60mm (300 x 300 DPI)  
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qRT-PCR validation of differentially expressed genes in vastus muscles from pre-dystrophic, four-week-old 
WT and FRG1 over-expressing mice. A selection of 56 differentially expressed genes obtained by Microarray 
analysis was validated using qRT-PCR. A heatmap of log2 fold change microarrays results (rigth side) and 
the corresponding log2 fold change qRT-PCR validation on independent animals (left side). Relative 
quantification for qRT-PCRs has been calculated using qbasePLUS software and the relative quantification 
mean from 3 WT mice has been used for each ratio calculation.  
95x104mm (300 x 300 DPI)  
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EID3 and FRG1 are specifically over-expressed in FSHD compared to healthy subjects and other muscular 
dystrophy controls. (A-D) Scattered plots of qRT-PCR performed in human muscle biopsies samples from 
heathy subjects, FSHD patients and other muscular dystrophy patients. (A) qRT-PCR for EID3 shows 
significant over-expression in FSHD compared to controls (one-way Anova: p=0.0029, n=7-8, mean ± 
SEM). (B) qRT-PCR for FRG1 shows significant over-expression in FSHD compared to controls (one-way 
Anova: p=0.0013, n=7-8, mean ± SEM). (C) qRT-PCR for SUV4-20H1 shows that SUV4-20H1 levels are not 
significantly different in FSHD muscle compared to healthy and other muscular dystrophy controls (one-way 
Anova test: p=ns, n=7–8, mean ± SEM). (D) qRT-PCR for β-glucuronidase (GUS) shows that SUV4-20H1 
levels are not significantly different in FSHD muscle compared to healthy and other muscular dystrophy 
controls (one-way Anova test: p=ns, n=7–8, mean ± SEM).  
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Supplementary Table I. Primers employed for cloning. 
 
Construct Primer Sequence 
Restriction 
site 
pCMV-HA-SUV4-20H1 forward 5’ aaGTCGAGgaagtggttgggagaatccaagaacatg 3’ SalI 
reverse 5’ aaGCGGCCGCttaggcattaagccttaaagact 3’ NotI 
pCMV-HA-Suv420h1 
(509-630) 
forward 5’aaGAATTCctaagaagaagaggaaggttggtcacaggca
gaatcatgggagaggtg 3’ 
EcoRI 
reverse 5’ aaCTCGAGtcagtctttcccagggaagctgtgctct 3’ XhoI 
pRSETA-FRG1 forward 5’ aaGGATCCgccgagtactcctatgtgaagtc 3’ BamHI 
reverse 5’ aaGAATTCtcacttgcagtatctgtcggctttc 3’ EcoRI 
pGEX2T-Suv420h1 
(509-874) 
forward 5’ aaGGATCCcacaggcagaatcatgggagaggtg 3’ BamHI 
reverse 5’ aaGAATTCtcatgcgttcagtcttagagactga 3’ EcoRI 
pGEX2T-Suv420h1 
(509-630) 
forward 5’ aaGGATCCcacaggcagaatcatgggagaggtg 3’ BamHI 
reverse 5’ aaGAATTCtcagtctttcccagggaagctgtgctct 3’ EcoRI 
pGEX2T-Suv420h1 
(631-754) 
forward 5’ aaGGATCCgggctgccagatttgccagggtctc 3’ BamHI 
reverse 5’ aaGAATTCtcacccgttactgagcttggcaacatag 3’ EcoRI 
pGEX2T-Suv420h1 
(755-874) 
forward 5’ aaGGATCCgtcagcgcagggccgggcagcagct 3’ BamHI 
reverse 5’ aaGAATTCtcatgcgttcagtcttagagactga 3’ EcoRI 
pIRESneo3-HA-Eid3 forward 5’ ttaaGAATTCaatctaaagaaaaatgttcc 3’ EcoRI 
reverse 5’ aattCTCGAGtctttaatatgagttttg 3’ XhoI 
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Supplementary Table II. Human biopsies related to experimental procedures. 
 
Sample Length of D4Z4 Sex Age Muscle 
Healthy 1 - - 40 Quadriceps femoris 
Healthy 2 - - 28 Quadriceps femoris 
Healthy 3 - - 28 Quadriceps femoris 
Healthy 4 - M 43 Biceps brachii 
Healthy 5 - F 38 Quadriceps femoris 
Healthy 6 - M 20 Triceps brachii 
Healthy 7 - F 54 Biceps brachii 
FSHD 1 20 kb F 27 Quadriceps femoris 
FSHD 2 21 kb F 29 Quadriceps femoris 
FSHD 3 - M 46 Quadriceps femoris 
FSHD 4 32 M 56 Biceps brachii 
FSHD 5 30 M 51 Biceps brachii 
FSHD 6 27 M 29 Biceps brachii 
FSHD 7 33 F 67 Biceps brachii 
Other MD 1 
Becker 
- M 23 Quadriceps femoris 
Other MD 2 
Becker 
- M 20 Quadriceps femoris 
Other MD 3 
Becker 
- M 37 Quadriceps femoris 
Other MD 4 
Becker 
- M 30 Quadriceps femoris 
Other MD 5 
Myotonic Dystrophy 1 
- M 45 Biceps brachii 
Other MD 6 - M 31 Biceps brachii 
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Calpainopathy 
Other MD 7 
Dysferlinopathy 
- F 43 Biceps brachii 
Other MD 8 
Dysferlinopathy 
- F 61 Biceps brachii 
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Supplementary Table III. Primers for qPCRs. 
 
Gene Primer Sequence Function 
GAPDH/ 
Gapdh 
forward 5’ TCAAGAAGGTGGTGAAGCAGG 3’ Reference 
reverse 5’ ACCAGGAAATGAGCTTGACAAA 3’ Reference 
FRG1/ 
Frg1 
forward 5’ AGTCCTCCAGAGCAGTTTAC 3’ Target 
reverse 5’ AATAAAGCAGCTATTTGAGGC 3’ Target 
FRG1 (for human 
biopsies) 
forward 5’ TCTACAGAGACGTAGGCTGTCA 3’ Target 
reverse 5’ CTTGAGCACGAGCTTGGTAG 3’ Target 
Eid3 forward 5’ AGTTCCTGGTTTTGGCCTCT 3’ Target 
reverse 5’ TCGCAGTCGCTAAATTCCTT 3’ Target 
Suv4-20h1 forward 5’ CAGAACAAAATGGAGCCAAGATAG 3’ Target 
reverse 5’ CGACCAGTTGACACAAACTTAC 3’ Target 
SUV4-20H1 forward 5’ AAATCCAGAGTGGGACTGCC 3’ Target 
reverse 5’ CTGAAGATTTTCGGTTAGAAGTTGC 3’ Target 
EID3 forward 5’ ATACCCGTGGCCGGCATGTT 3’ Target 
reverse 5’ ACTTCGCCGCGTACTCGCTA 3’ Target 
GUS ( from Krom 
et al., 2012) 
forward 5’ CTCATTTGGAATTTTGCCGATT 3’ Target 
reverse 5’ CCGAGTGAAGATCCCCTTTTTA 3’ Target 
Suv420h1
flox 
forward 5’ TGGCGATTGAGCGGTACCG 3’ Target 
reverse 5’ GCCTCACTCTCTGAGTGCTGGAATC 3’ Target 
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